The PRDM12 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal recessive hereditary sensory and autonomic neuropathy type VIII (PMID: 26005867).
Order this gene as a single gene test.
Invitae tests that include this gene:
The PRDM12 gene encodes a transcriptional regulator that mediates the methylation of histone H3 lysine 9 (H3K9) through its interaction with a histone methyltransferase. The proposed role of the PRDM12-mediated H3K9 methylation is transcriptional gene regulation during neural crest cells specification, specifically in the neurogenesis of nociceptors, the neural cells that respond to potentially damaging stimuli.
Invitae is a College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified clinical diagnostic laboratory performing full-gene sequencing and deletion/duplication analysis using next-generation sequencing technology (NGS).
Our sequence analysis covers clinically important regions of each gene, including coding exons, +/- 10 base pairs of adjacent intronic sequence in the transcript listed below. In addition, analysis covers the select non-coding variants specifically defined in the table below. Any variants that fall outside these regions are not analyzed. Any specific limitations in the analysis of these genes are also listed in the table below.
Our analysis detects most intragenic deletions and duplications at single exon resolution. However, in rare situations, single-exon copy number events may not be analyzed due to inherent sequence properties or isolated reduction in data quality. If you are requesting the detection of a specific single-exon copy number variation, please contact Client Services before placing your order.
|Gene||Transcript reference||Sequencing analysis||Deletion/Duplication analysis|